APA

Humar A., Limaye A. P., Blumberg E. A., Hauser I. A., Vincenti F., Jardine A. G., Abramowicz D., Ives J. A. L., Farhan M. & Peeters P. (20110128). Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study. : Transplantation.

Chicago

Humar Atul, Limaye Ajit P, Blumberg Emily A, Hauser Ingeborg A, Vincenti Flavio, Jardine Alan G, Abramowicz Daniel, Ives Jane A L, Farhan Mahdi and Peeters Patrick. 20110128. Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study. : Transplantation.

Harvard

Humar A., Limaye A. P., Blumberg E. A., Hauser I. A., Vincenti F., Jardine A. G., Abramowicz D., Ives J. A. L., Farhan M. and Peeters P. (20110128). Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study. : Transplantation.

MLA

Humar Atul, Limaye Ajit P, Blumberg Emily A, Hauser Ingeborg A, Vincenti Flavio, Jardine Alan G, Abramowicz Daniel, Ives Jane A L, Farhan Mahdi and Peeters Patrick. Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study. : Transplantation. 20110128.